CompletedPhase 4

Comparison of Efficacy of Topical Westerhoff Formula Cream Vs Topical 4% Hydroquinone for the Treatment of Melasma

Pakistan50 participantsStarted 2025-07-18

Plain-language summary

study was conducted on middle aged male and female, including families and health care professional also.

Who can participate

Age range15 Years – 45 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * patient with facial melasma of age between 15 years to 45 years of both gender Exclusion Criteria: * patient who have already taken treatment within 8 weeks, pregnant women, who are taking hormonals therapy and patient of dementia

What they're measuring

proportion of participants achieving 60% reduction in the melasma area severity index (MASI-60)

Timeframe: 8 weeks

proportion of participants achieving >60% reduction in Melasma Area and severity index (MASI-60)

Timeframe: baseline to 8 weeks

Trial details

NCT IDNCT07508098

SponsorPak Emirates Military Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-01-19

View on ClinicalTrials.gov More Melasma (Facial Melasma) trials